AT22449T - Dynorphinamidanaloge. - Google Patents

Dynorphinamidanaloge.

Info

Publication number
AT22449T
AT22449T AT83303313T AT83303313T AT22449T AT 22449 T AT22449 T AT 22449T AT 83303313 T AT83303313 T AT 83303313T AT 83303313 T AT83303313 T AT 83303313T AT 22449 T AT22449 T AT 22449T
Authority
AT
Austria
Prior art keywords
dynorphinamidanaloge
Prior art date
Application number
AT83303313T
Other languages
German (de)
Inventor
Nancy M Lee
Horace H Loh
Jaw-Kang Chang
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US06/387,005 priority Critical patent/US4462941A/en
Application filed by Univ California filed Critical Univ California
Priority to EP83303313A priority patent/EP0096592B1/en
Publication of AT22449T publication Critical patent/AT22449T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
AT83303313T 1982-06-10 1983-06-08 Dynorphinamidanaloge. AT22449T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US06/387,005 US4462941A (en) 1982-06-10 1982-06-10 Dynorphin amide analogs
EP83303313A EP0096592B1 (en) 1982-06-10 1983-06-08 Dynorphin amide analogs

Publications (1)

Publication Number Publication Date
AT22449T true AT22449T (en) 1986-10-15

Family

ID=23528034

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83303313T AT22449T (en) 1982-06-10 1983-06-08 Dynorphinamidanaloge.

Country Status (15)

Country Link
US (1) US4462941A (en)
EP (1) EP0096592B1 (en)
JP (1) JPH0427995B2 (en)
KR (1) KR840005080A (en)
AT (1) AT22449T (en)
AU (1) AU1448983A (en)
CA (1) CA1241645A (en)
DE (1) DE3366428D1 (en)
DK (1) DK262683A (en)
FI (1) FI832095L (en)
IL (1) IL68825D0 (en)
IS (1) IS2812A7 (en)
NO (1) NO832107L (en)
PT (1) PT76860B (en)
ZA (1) ZA8304189B (en)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59141547A (en) * 1983-02-01 1984-08-14 Eisai Co Ltd Novel peptide having analgesic action and its preparation
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
US5242798A (en) * 1983-07-21 1993-09-07 Scripps Clinic And Research Foundation Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same
US4900811A (en) * 1983-07-21 1990-02-13 Scripps Clinic And Research Foundation Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same
EP0147194B1 (en) * 1983-12-22 1989-07-19 Yoshio Hosobuchi Compositions for treating cerebral ischemia
JPH0680079B2 (en) * 1984-11-09 1994-10-12 エーザイ株式会社 Polypeptide
US5017689A (en) * 1989-07-06 1991-05-21 Arizona Technology Development Corporation Dynorphin analogs specific for kappa opioid receptors
US5807827A (en) * 1992-06-12 1998-09-15 Des-Tyr Dynorphin Partnership Des-Tyr dynorphin analogues
US5817628A (en) * 1992-12-02 1998-10-06 The Rockefeller University Dynorphin a suppression of natural killer cell activity
US5482930A (en) * 1993-06-09 1996-01-09 The Regents Of The University Of California Anti-inflammatory composition and method with des-Tyr dynorphin and analogues
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
WO1996006626A1 (en) * 1994-08-26 1996-03-07 Lee Nancy M Analgesic method with dynorphin analogues truncated at the n-terminus
EP1327447B1 (en) * 1997-09-04 2011-05-25 Novoneuron, Inc. Noribogaine in the treatment of pain and drug addiction
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
US6437092B1 (en) 1998-11-06 2002-08-20 Conjuchem, Inc. Conjugates of opioids and endogenous carriers
US6605648B1 (en) * 1999-04-06 2003-08-12 Phillips Plastics Corporation Sinterable structures and method
US7601691B2 (en) 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
EA003922B1 (en) * 1999-05-17 2003-10-30 Конджачем, Инк. Long lasting insulinotropic peptides
EP2100901A1 (en) 1999-05-17 2009-09-16 ConjuChem Biotechnologies Inc. Modified Insulin and conjugates thereof
US6849714B1 (en) 1999-05-17 2005-02-01 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
US20090175821A1 (en) * 1999-05-17 2009-07-09 Bridon Dominique P Modified therapeutic peptides with extended half-lives in vivo
US6706892B1 (en) * 1999-09-07 2004-03-16 Conjuchem, Inc. Pulmonary delivery for bioconjugation
US6887470B1 (en) 1999-09-10 2005-05-03 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
DE60032255T2 (en) * 1999-10-04 2007-06-28 Nektar Therapeutics Al, Corp., Huntsville Polymer-stabilized neuropeptides
US6514500B1 (en) 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
CN101696240A (en) * 2001-02-02 2010-04-21 康久化学生物技术公司; Long lasting growth hormone releasing factor derivatives
PT1360202E (en) * 2001-02-16 2008-09-01 Conjuchem Biotechnologies Inc Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US20040266673A1 (en) * 2002-07-31 2004-12-30 Peter Bakis Long lasting natriuretic peptide derivatives
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
US8075872B2 (en) * 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10336400A1 (en) * 2003-08-06 2005-03-24 Grünenthal GmbH Abuse-proofed dosage form
EP2230257A1 (en) * 2004-04-23 2010-09-22 ConjuChem Biotechnologies Inc. Method for the purification of albumin conjugates
DE102004032051A1 (en) * 2004-07-01 2006-01-19 Grünenthal GmbH A process for preparing a secured against misuse, solid dosage form
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
EP1809104A4 (en) * 2004-09-23 2009-04-29 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Unbreakable dosage forms with delayed release
US8039432B2 (en) * 2005-11-09 2011-10-18 Conjuchem, Llc Method of treatment of diabetes and/or obesity with reduced nausea side effect
US20070269863A1 (en) * 2005-12-22 2007-11-22 Bridon Dominique P Process for the production of preformed conjugates of albumin and a therapeutic agent
WO2008077194A1 (en) * 2006-12-22 2008-07-03 Xenome Ltd Receptor agonists
US20090099074A1 (en) * 2007-01-10 2009-04-16 Conjuchem Biotechnologies Inc. Modulating food intake
DE102007011485A1 (en) 2007-03-07 2008-09-11 Grünenthal GmbH Dosage form with impeded abuse
CA2708762A1 (en) * 2007-12-11 2009-06-18 Conjuchem Biotechnologies Inc. Formulation of insulinotropic peptide conjugates
TWI454288B (en) 2008-01-25 2014-10-01 Gruenenthal Chemie Pharmaceutical dosage form
CA2723438C (en) 2008-05-09 2016-10-11 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
CA2767888C (en) 2009-07-22 2017-09-12 Gruenenthal Gmbh Tamper-resistant dosage form for oxidation-sensitive opioids
PE10672012A1 (en) 2009-07-22 2012-09-05 Gruenenthal Chemie Form of controlled release dosage extruded by hot melt
CN102821757B (en) 2010-02-03 2016-01-20 格吕伦塔尔有限公司 Preparation of a powdered pharmaceutical composition by an extruder
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
JP6049615B2 (en) 2010-07-23 2016-12-21 デマークス・インコーポレイテッドDemerx,Inc. Noribogain composition
JP5933553B2 (en) 2010-09-02 2016-06-15 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Abuse-resistant dosage form comprising an anionic polymer
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
HUE034711T2 (en) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
CA2855994A1 (en) 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
WO2013112673A1 (en) 2012-01-25 2013-08-01 Demerx, Inc. Synthetic voacangine
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
EP2934541A4 (en) 2012-12-20 2016-08-03 Demerx Inc Substituted noribogaine
WO2014190313A2 (en) 2013-05-24 2014-11-27 The Arizona Board Of Regents On Behalf Of The University Of Arizona Dynorphin a analogs with bradykinin receptors specificity for modulation of neuropathic pain
JP6445537B2 (en) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Modified anti containing one or more particles (tamper-resistant) dosage forms
CA2913209A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
JP2017518980A (en) 2014-05-12 2017-07-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Containing tapentadol, modified prevent immediate release capsule formulation
MX2016015417A (en) 2014-05-26 2017-02-22 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping.
CA2989550A1 (en) 2014-06-18 2015-12-23 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
KR20170139158A (en) 2015-04-24 2017-12-18 그뤼넨탈 게엠베하 Immediately released and prevent the tamper-resistant dosage form extraction solvent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5572153A (en) * 1978-11-26 1980-05-30 Shionogi & Co Ltd Undecapeptide
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
US4361553A (en) * 1981-05-18 1982-11-30 Regents Of The University Of California Therapeutic uses of dynorphin
JPH032880B2 (en) * 1981-07-21 1991-01-17 Eisai Co Ltd

Also Published As

Publication number Publication date
CA1241645A (en) 1988-09-06
IL68825D0 (en) 1983-09-30
AU1448983A (en) 1983-12-15
JPS5925365A (en) 1984-02-09
FI832095L (en) 1983-12-11
CA1241645A1 (en)
FI832095A0 (en) 1983-06-10
DK262683A (en) 1983-12-11
FI832095A (en)
FI832095D0 (en)
EP0096592A1 (en) 1983-12-21
KR840005080A (en) 1984-11-03
NO832107L (en) 1983-12-12
DE3366428D1 (en) 1986-10-30
IS2812A7 (en) 1983-10-07
EP0096592B1 (en) 1986-09-24
DK262683D0 (en) 1983-06-09
PT76860B (en) 1986-01-27
JPH0427995B2 (en) 1992-05-13
US4462941A (en) 1984-07-31
PT76860A (en) 1983-07-01
ZA8304189B (en) 1984-02-29

Similar Documents

Publication Publication Date Title
NO159338C (en) Kartransplantat.
NO154114C (en) Perfusjonsdobbeltkateter.
NO158418B (en) Soetningsmidler.
NO156353C (en) Snorlÿs.
DE3382431D1 (en) Steuerungsgeraet.
DE3381307D1 (en) Bildverarbeitungsgeraet.
DE3381663D1 (en) Primaerschutzschalter.
DE3381735D1 (en) Drehtuersystem.
DE3382572T2 (en) Antibodies-connections.
NO832709L (en) Tetningstrykkreduseringssystem.
DE3381463D1 (en) Stehbildaufnahmegeraet.
DE3382414D1 (en) Gefaessdurchlaessigkeitsfaktor.
AT22449T (en) Dynorphinamidanaloge.
DE93512T1 (en) Katheterfuehrung.
DE88527T1 (en) Adhesionsvermittler.
NO163288C (en) Co-vulcanizable perfluorelastomerblanding.
DE3381048D1 (en) Fluessigkristallzusammensetzungen.
DE3381820D1 (en) Cyklonabtrenner.
NO834552L (en) Varmeduk.
AT43828T (en) Hydroterphenyle.
DE3382220D1 (en) Fernsehuebertragungssystem.
DE100143T1 (en) Kreisbahnfoerderer.
DE96179T1 (en) Mehrschichtenextruderduese.
DE3382681T2 (en) Blutfraktionierungssystem.
AT29661T (en) Tubenpessar.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee